tiprankstipranks
Trending News
More News >
Wuxi Biologics (Cayman) Inc. (HK:2269)
:2269
Hong Kong Market

Wuxi Biologics (Cayman) (2269) Financial Statements

Compare
40 Followers

Wuxi Biologics (Cayman) Financial Overview

Wuxi Biologics (Cayman)'s market cap is currently $96.93B. The company's EPS TTM is HK$0.886; its P/E ratio is 26.05; Wuxi Biologics (Cayman) is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is HK$0.48. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 18.68B¥ 17.03B¥ 15.27B¥ 10.29B¥ 5.61B
Gross Profit¥ 7.65B¥ 6.83B¥ 6.72B¥ 4.83B¥ 2.53B
Operating Income¥ 4.97B¥ 3.95B¥ 6.16B¥ 3.86B¥ 1.76B
EBITDA¥ 6.43B¥ 5.50B¥ 6.22B¥ 4.51B¥ 2.31B
Net Income¥ 3.36B¥ 3.40B¥ 4.42B¥ 3.39B¥ 1.69B
Balance Sheet
Cash & Short-Term Investments¥ 10.71B¥ 11.24B¥ 8.71B¥ 11.13B¥ 8.48B
Total Assets¥ 56.98B¥ 56.58B¥ 49.56B¥ 44.03B¥ 28.96B
Total Debt¥ 4.94B¥ 4.56B¥ 4.42B¥ 4.30B¥ 3.33B
Net Debt¥ -3.34B¥ -5.11B¥ -1.97B¥ -4.71B¥ -3.76B
Total Liabilities¥ 11.50B¥ 12.56B¥ 13.35B¥ 11.33B¥ 8.06B
Stockholders' Equity¥ 41.82B¥ 40.33B¥ 35.05B¥ 32.28B¥ 20.56B
Cash Flow
Free Cash Flow¥ 1.29B¥ 437.20M¥ -326.72M¥ -3.09B¥ -4.14B
Operating Cash Flow¥ 5.22B¥ 4.67B¥ 5.54B¥ 3.43B¥ 1.88B
Investing Cash Flow¥ -3.94B¥ -3.23B¥ -5.91B¥ -9.60B¥ -7.22B
Financing Cash Flow¥ -2.75B¥ 1.96B¥ -2.59B¥ 8.21B¥ 6.57B
Currency in CNY

Wuxi Biologics (Cayman) Earnings and Revenue History

Wuxi Biologics (Cayman) Debt to Assets

Wuxi Biologics (Cayman) Cash Flow

Wuxi Biologics (Cayman) Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis